DWP14012 20 mg placebo
Sponsors
Daewoong Pharmaceutical Co. LTD.
Conditions
Healed Erosive Esophagitis
Phase 3
Study to Evaluate the Efficacy and Safety of DWP14012 on Maintaining Healing in Subjects With Healed Erosive Esophagitis
NCT04341428
Start: 2020-07-02End: 2021-12-30Target: 406Updated: 2020-09-03
Efficacy and Safety of DWP14012 for Long-Term Maintenance Therapy in Patients With Healed Erosive Esophagitis
Not yet recruitingNCT07746518
Start: 2026-09-01End: 2030-03-01Target: 420Updated: 2026-08-13